Table of Contents Author Guidelines Submit a Manuscript
Depression Research and Treatment
Volume 2011, Article ID 762139, 11 pages
http://dx.doi.org/10.1155/2011/762139
Review Article

Potential Antidepressant Role of Neurotransmitter CART: Implications for Mental Disorders

1The Division of Neuroscience, Oregon National Primate Research Center, Oregon Health and Science University, 505 NW 185th Avenue, Beaverton, OR 97006, USA
2The Department of Public Health and Preventive Medicine, the Knight Cancer Institute, Oregon Health and Science University, Portland, OR 97239, USA

Received 1 February 2011; Revised 20 April 2011; Accepted 16 May 2011

Academic Editor: Ronald S. Duman

Copyright © 2011 Peizhong Mao. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. J. L. Murray and A. D. Lopez, “Evidence-based health policy—lessons from the global burden of disease study,” Science, vol. 274, no. 5288, pp. 740–743, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. O. Berton and E. J. Nestler, “New approaches to antidepressant drug discovery: beyond monoamines,” Nature Reviews Neuroscience, vol. 7, no. 2, pp. 137–151, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. A. D. Lopez and C. C. Murray, “The global burden of disease, 1990–2020,” Nature Medicine, vol. 4, no. 11, pp. 1241–1243, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Krishnan and E. J. Nestler, “Linking molecules to mood: new insight into the biology of depression,” American Journal of Psychiatry, vol. 167, no. 11, pp. 1305–1320, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. E. J. Nestler, M. Barrot, R. J. DiLeone, A. J. Eisch, S. J. Gold, and L. M. Monteggia, “Neurobiology of depression,” Neuron, vol. 34, no. 1, pp. 13–25, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), American Psychiatric Publishing, Washington, DC, USA, 1994.
  7. J. Douglass, A. A. McKinzie, and P. Couceyro, “PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine,” Journal of Neuroscience, vol. 15, no. 3, pp. 2471–2481, 1995. View at Google Scholar · View at Scopus
  8. M. J. Kuhar, L. D. Adams, R. G. Hunter, S. D. Vechia, and Y. Smith, “CART peptides,” Regulatory Peptides, vol. 89, no. 1–3, pp. 1–6, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. R. G. Hunter, K. Philpot, A. Vicentic, G. Dominguez, G. W. Hubert, and M. J. Kuhar, “CART in feeding and obesity,” Trends in Endocrinology and Metabolism, vol. 15, no. 9, pp. 454–459, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Rogge, D. Jones, G. W. Hubert et al., “CART peptides: regulators of body weight, reward and other functions,” Nature Reviews Neuroscience, vol. 9, no. 10, pp. 747–758, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. C. U. Pae, C. Lee, and I. H. Paik, “Therapeutic implication of cocaine- and amphetamine-regulated transcript (CART) in the treatment of depression,” Medical Hypotheses, vol. 69, no. 1, pp. 132–135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Mao, A. Ardeshiri, R. Jacks et al., “Mitochondrial mechanism of neuroprotection by CART,” European Journal of Neuroscience, vol. 26, no. 3, pp. 624–632, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Haenisch and H. Bönisch, “Depression and antidepressants: insights from knockout of dopamine, serotonin or noradrenaline re-uptake transporters,” Pharmacology and Therapeutics, vol. 129, no. 3, pp. 352–368, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Bonnin, N. Goeden, K. Chen et al., “A transient placental source of serotonin for the fetal forebrain,” Nature, vol. 472, no. 7343, pp. 347–350, 2011. View at Publisher · View at Google Scholar
  15. S. I. Shyn and S. P. Hamilton, “The genetics of major depression: moving beyond the monoamine hypothesis,” Psychiatric Clinics of North America, vol. 33, no. 1, pp. 125–140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Gong, Y. Chai, J. H. Ding, X. L. Sun, and G. Hu, “Chronic mild stress damages mitochondrial ultrastructure and function in mouse brain,” Neuroscience Letters, vol. 488, no. 1, pp. 76–80, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Gardner and R. G. Boles, “Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 35, no. 3, pp. 730–743, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Maes, “Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 35, no. 3, pp. 664–675, 2011. View at Publisher · View at Google Scholar
  19. M. Rietschel, M. Mattheisen, J. Frank et al., “Genome-wide association-, replication-, and neuroimaging study implicates homer1 in the etiology of major depression,” Biological Psychiatry, vol. 68, no. 6, pp. 578–585, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Orsetti, F. Di Brisco, P. L. Canonico, A. A. Genazzani, and P. Ghi, “Gene regulation in the frontal cortex of rats exposed to the chronic mild stress paradigm, an animal model of human depression,” European Journal of Neuroscience, vol. 27, no. 8, pp. 2156–2164, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Conn and L. Thorpe, “Assessment of behavioural and psychological symptoms associated with dementia,” Canadian Journal of Neurological Sciences, vol. 34, supplement 1, pp. S67–S71, 2007. View at Google Scholar · View at Scopus
  22. K. Karttunen, P. Karppi, A. Hiltunen et al., “Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease,” International Journal of Geriatric Psychiatry, vol. 26, no. 5, pp. 473–482, 2011. View at Publisher · View at Google Scholar
  23. P. Mao and P. H. Reddy, “Is multiple sclerosis a mitochondrial disease?” Biochimica et Biophysica Acta, vol. 1802, no. 1, pp. 66–79, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. A. DeMichele-Sweet and R. A. Sweet, “Genetics of psychosis in Alzheimer's disease: a review,” Journal of Alzheimer's Disease, vol. 19, no. 3, pp. 761–780, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Shioda, Y. Yamamoto, F. Han et al., “A novel cognitive enhancer, ZSET1446/ST101, promotes hippocampal neurogenesis and ameliorates depressive behavior in olfactory bulbectomized mice,” Journal of Pharmacology and Experimental Therapeutics, vol. 333, no. 1, pp. 43–50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. R. S. Duman and L. M. Monteggia, “A neurotrophic model for stress-related mood disorders,” Biological Psychiatry, vol. 59, no. 12, pp. 1116–1127, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Castrén and T. Rantamäki, “The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity,” Developmental Neurobiology, vol. 70, no. 5, pp. 289–297, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Castrén, V. Võikar, and T. Rantamäki, “Role of neurotrophic factors in depression,” Current Opinion in Pharmacology, vol. 7, no. 1, pp. 18–21, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. R. S. Duman, “Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression,” Dialogues in Clinical Neuroscience, vol. 11, no. 3, pp. 239–255, 2009. View at Google Scholar · View at Scopus
  30. J. Douglass and S. Daoud, “Characterization of the human cDNA and genomic DNA encoding CART: a cocaine-and amphetamine-regulated transcript,” Gene, vol. 169, no. 2, pp. 241–245, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Thim, P. Kristensen, P. F. Nielsen, B. S. Wulff, and J. T. Clausen, “Tissue-specific processing of cocaine- and amphetamine-regulated transcript peptides in the rat,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 6, pp. 2722–2727, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. P. R. Couceyro, E. O. Koylu, and M. J. Kuhar, “Further studies on the anatomical distribution of CART by in situ hybridization,” Journal of Chemical Neuroanatomy, vol. 12, no. 4, pp. 229–241, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. E. O. Koylu, P. R. Couceyro, P. D. Lambert, N. C. Ling, E. B. DeSouza, and M. J. Kuhar, “Immunohistochemical localization of novel CART peptides in rat hypothalamus, pituitary and adrenal gland,” Journal of Neuroendocrinology, vol. 9, no. 11, pp. 823–833, 1997. View at Google Scholar · View at Scopus
  34. P. Kristensen, M. E. Judge, L. Thim et al., “Hypothalamic CART is a new anorectic peptide regulated by leptin,” Nature, vol. 393, no. 6680, pp. 72–76, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. M. A. Asnicar, D. P. Smith, D. D. Yang et al., “Absence of cocaine- and amphetamine-regulated transcript results in obesity in mice fed a high caloric diet,” Endocrinology, vol. 142, no. 10, pp. 4394–4400, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. N. Wierup, W. G. Richards, and A. W. Bannon, “CART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight,” Regulatory Peptides, vol. 129, no. 1–3, pp. 203–211, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Ludvigsen, L. Thim, A. M. Blom, and B. S. Wulff, “Solution structure of the satiety factor, CART, reveals new functionality of a well-known fold,” Biochemistry, vol. 40, no. 31, pp. 9082–9088, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. A. J. Kastin and V. Akerstrom, “Entry of CART into brain is rapid but not inhibited by excess CART or leptin,” American Journal of Physiology, vol. 277, no. 5, pp. E901–E904, 1999. View at Google Scholar · View at Scopus
  39. P. Mao and R. Jacks, “Transcriptional activity by cocaine-amphetamine-regulated transcript,” Molecular Psychiatry, vol. 12, no. 3, pp. 223–224, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. P. M. Pitychoutis and Z. Papadopoulou-Daifoti, “Of depression and immunity: does sex matter?” International Journal of Neuropsychopharmacology, vol. 13, no. 5, pp. 675–689, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. A. L. Curtis, T. Bethea, and R. J. Valentino, “Sexually dimorphic responses of the brain norepinephrine system to stress and corticotropin-releasing factor,” Neuropsychopharmacology, vol. 31, no. 3, pp. 544–554, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. D. A. Bangasser, A. Curtis, B. A. Reyes et al., “Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology,” Molecular Psychiatry, vol. 15, no. 9, pp. 896–904, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. D. A. Bangasser, X. Zhang, V. Garachh, E. Hanhauser, and R. J. Valentino, “Sexual dimorphism in locus coeruleus dendritic morphology: a structural basis for sex differences in emotional arousal,” Physiology and Behavior, vol. 103, no. 3-4, pp. 342–351, 2011. View at Publisher · View at Google Scholar
  44. N. M. Derks, B. Gaszner, K. Bernhardt, E. W. Roubos, and T. Kozicz, “Sex-specific expression of BDNF and CART in the midbrain non-preganglionic Edinger-Westphal nucleus in the rat,” Peptides, vol. 30, no. 12, pp. 2268–2274, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Xu, B. Bloem, B. Gaszner, E. W. Roubos, and T. Kozicz, “Stress-related changes in the activity of cocaine- and amphetamine-regulated transcript and nesfatin neurons in the midbrain non-preganglionic Edinger-Westphal nucleus in the rat,” Neuroscience, vol. 170, no. 2, pp. 478–488, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. B. Okere, L. Xu, E. W. Roubos, D. Sonetti, and T. Kozicz, “Restraint stress alters the secretory activity of neurons co-expressing urocortin-1, cocaine- and amphetamine-regulated transcript peptide and nesfatin-1 in the mouse Edinger-Westphal nucleus,” Brain Research, vol. 1317, no. 1, pp. 92–99, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Liang, D. M. Byers, and L. N. Irwin, “Chronic mild stressors and diet affect gene expression differently in male and female rats,” Journal of Molecular Neuroscience, vol. 33, no. 2, pp. 189–200, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. P. Fagergren and Y. L. Hurd, “Mesolimbic gender differences in peptide CART mRNA expression: effects of cocaine,” NeuroReport, vol. 10, no. 16, pp. 3449–3452, 1999. View at Google Scholar · View at Scopus
  49. R. G. Hunter, R. Bellani, E. Bloss, A. Costa, R. D. Romeo, and B. S. McEwen, “Regulation of CART mRNA by stress and corticosteroids in the hippocampus and amygdala,” Brain Research, vol. 1152, no. 1-2, pp. 234–240, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Pinos, P. Collado, M. Rodríguez-Zafra, C. Rodríguez, S. Segovia, and A. Guillamón, “The development of sex differences in the locus coeruleus of the rat,” Brain Research Bulletin, vol. 56, no. 1, pp. 73–78, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Cahill, “Why sex matters for neuroscience,” Nature Reviews Neuroscience, vol. 7, no. 6, pp. 477–484, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. B. S. McEwen, “Stress, sex, and neural adaptation to a changing environment: mechanisms of neuronal remodeling,” Annals of the New York Academy of Sciences, vol. 1204, supplement, pp. E38–E59, 2010. View at Google Scholar · View at Scopus
  53. R. P. Millar, “GnRHs and GnRH receptors,” Animal Reproduction Science, vol. 88, no. 1-2, pp. 5–28, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. M. C. Lebrethon, E. Vandersmissen, A. Gérard, A. S. Parent, and J. P. Bourguignon, “Cocaine and amphetamine-regulated-transcript peptide mediation of leptin stimulatory effect on the rat gonadotropin-releasing hormone pulse generator in vitro,” Journal of Neuroendocrinology, vol. 12, no. 5, pp. 383–385, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. L. D. McCullough and P. D. Hurn, “Estrogen and ischemic neuroprotection: an integrated view,” Trends in Endocrinology and Metabolism, vol. 14, no. 5, pp. 228–235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. C. L. Bethea, A. P. Reddy, Y. Tokuyama, J. A. Henderson, and F. B. Lima, “Protective actions of ovarian hormones in the serotonin system of macaques,” Frontiers in Neuroendocrinology, vol. 30, no. 2, pp. 212–238, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Liu, M. H. Kelley, P. S. Herson, and P. Hurn, “Neuroprotection of sex steroids,” Minerva Endocrinologica, vol. 35, no. 2, pp. 127–143, 2010. View at Google Scholar · View at Scopus
  58. R. M. Shansky, C. Hamo, P. R. Hof, W. Lou, B. S. McEwen, and J. H. Morrison, “Estrogen promotes stress sensitivity in a prefrontal cortex-amygdala pathway,” Cerebral Cortex, vol. 20, no. 11, pp. 2560–2567, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Xu, W. Zhang, J. Klaus et al., “Role of cocaine- and amphetamine-regulated transcript in estradiol-mediated neuroprotection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 39, pp. 14489–14494, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. B. Wu, S. Hu, M. Yang, H. Pan, and S. Zhu, “CART peptide promotes the survival of hippocampal neurons by upregulating brain-derived neurotrophic factor,” Biochemical and Biophysical Research Communications, vol. 347, no. 3, pp. 656–661, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. S. D. Kuipers and C. R. Bramham, “Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy,” Current Opinion in Drug Discovery and Development, vol. 9, no. 5, pp. 580–586, 2006. View at Google Scholar · View at Scopus
  62. E. Castrén and T. Rantamäki, “The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity,” Developmental Neurobiology, vol. 70, no. 5, pp. 289–297, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. E. O. Koylu, P. R. Couceyro, P. D. Lambert, and M. J. Kuhar, “Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain,” Journal of Comparative Neurology, vol. 391, no. 1, pp. 115–132, 1998. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Wiehager, D. I. Beiderbeck, S. H. M. Gruber et al., “Increased levels of cocaine and amphetamine regulated transcript in two animal models of depression and anxiety,” Neurobiology of Disease, vol. 34, no. 2, pp. 375–380, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. B. S. McEwen, “Physiology and neurobiology of stress and adaptation: central role of the brain,” Physiological Reviews, vol. 87, no. 3, pp. 873–904, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. M. P. Dandekar, P. S. Singru, D. M. Kokare, and N. K. Subhedar, “Cocaine- and amphetamine-regulated transcript peptide plays a role in the manifestation of depression: social isolation and olfactory bulbectomy models reveal unifying principles,” Neuropsychopharmacology, vol. 34, no. 5, pp. 1288–1300, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. M. S. Roh, F. J. Cui, Y. M. Ahn, and U. G. Kang, “Up-regulation of cocaine- and amphetamine-regulated transcript (CART) in the rat nucleus accumbens after repeated electroconvulsive shock,” Neuroscience Research, vol. 65, no. 2, pp. 210–213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. J. K. Soczynska, S. H. Kennedy, H. O. Woldeyohannes et al., “Mood disorders and obesity: understanding inflammation as a pathophysiological nexus,” NeuroMolecular Medicine, vol. 13, no. 2, pp. 93–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. J. N. Jaworski, S. T. Hansen, M. J. Kuhar, and G. P. Mark, “Injection of CART (cocaine- and amphetamine-regulated transcript) peptide into the nucleus accumbens reduces cocaine self-administration in rats,” Behavioural Brain Research, vol. 191, no. 2, pp. 266–271, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. K. T. Nakhate, D. M. Kokare, P. S. Singru, and N. K. Subhedar, “Central regulation of feeding behavior during social isolation of rat: evidence for the role of endogenous CART system,” International Journal of Obesity, vol. 35, pp. 773–784, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. E. M. del Giudice, N. Santoro, P. Fiumani, G. Dominguez, M. J. Kuhar, and L. Perrone, “Adolescents carrying a missense mutation in the cart gene exhibit increased anxiety and depression,” Depression and Anxiety, vol. 23, no. 2, pp. 90–92, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. E. M. del Giudice, N. Santoro, G. Cirillo et al., “Mutational screening of the CART gene in obese children: identifying a mutation (Leu34Phe) associated with reduced resting energy expenditure and cosegregating with obesity phenotype in a large family,” Diabetes, vol. 50, no. 9, pp. 2157–2160, 2001. View at Google Scholar · View at Scopus
  73. A. M. Bao, G. Meynen, and D. F. Swaab, “The stress system in depression and neurodegeneration: focus on the human hypothalamus,” Brain Research Reviews, vol. 57, no. 2, pp. 531–553, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. E. O. Koylu, P. R. Couceyro, P. D. Lambert, N. C. Ling, E. B. DeSouza, and M. J. Kuhar, “Immunohistochemical localization of novel CART peptides in rat hypothalamus, pituitary and adrenal gland,” Journal of Neuroendocrinology, vol. 9, no. 11, pp. 823–833, 1997. View at Google Scholar · View at Scopus
  75. P. R. Couceyro, E. O. Koylu, and M. J. Kuhar, “Further studies on the anatomical distribution of CART by in situ hybridization,” Journal of Chemical Neuroanatomy, vol. 12, no. 4, pp. 229–241, 1997. View at Publisher · View at Google Scholar · View at Scopus
  76. P. J. Larsen, V. Seier, A. Fink-Jensen, J. J. Holst, J. Warberg, and N. Vrang, “Cocaine- and amphetamine-regulated transcript is present in hypothalamic neuroendocrine neurones and is released to the hypothalamic-pituitary portal circuit,” Journal of Neuroendocrinology, vol. 15, no. 3, pp. 219–226, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. A. Vicentic, “CART peptide diurnal variations in blood and brain,” Peptides, vol. 27, no. 8, pp. 1942–1948, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. S. Sarkar, G. Wittmann, C. Fekete, and R. M. Lechan, “Central administration of cocaine- and amphetamine-regulated transcript increases phosphorylation of cAMP response element binding protein in corticotropin-releasing hormone-producing neurons but not in prothyrotropin-releasing hormone-producing neurons in the hypothalamic paraventricular nucleus,” Brain Research, vol. 999, no. 2, pp. 181–192, 2004. View at Publisher · View at Google Scholar · View at Scopus
  79. S. M. Smith, J. M. Vaughan, and C. J. Donaldson, “Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism,” Endocrinology, vol. 145, no. 11, pp. 5202–5209, 2004. View at Publisher · View at Google Scholar · View at Scopus
  80. S. A. Stanley, C. J. Small, K. G. Murphy et al., “Actions of cocaine- and amphetamine-regulated transcript (CART) peptide on regulation of appetite and hypothalamo-pituitary axes in vitro and in vivo in male rats,” Brain Research, vol. 893, no. 1-2, pp. 186–194, 2001. View at Publisher · View at Google Scholar · View at Scopus
  81. B. Baranowska, E. Wolinska-Witort, W. Bik, A. Baranowska-Bik, L. Martynska, and M. Chmielowska, “The effect of cocaine-amphetamine regulated transcript (CART) on the activation of the pituitary-adrenal axis,” Neuroendocrinology Letters, vol. 27, no. 1-2, pp. 60–62, 2006. View at Google Scholar · View at Scopus
  82. E. O. Koylu, B. Balkan, M. J. Kuhar, and S. Pogun, “Cocaine and amphetamine regulated transcript (CART) and the stress response,” Peptides, vol. 27, no. 8, pp. 1956–1969, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. M. E. Keck, “Corticotropin-releasing factor, vasopressin and receptor systems in depression and anxiety,” Amino Acids, vol. 31, no. 3, pp. 241–250, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. F. Fumagalli, R. Molteni, F. Calabrese, A. Frasca, G. Racagni, and M. A. Riva, “Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain,” Journal of Neurochemistry, vol. 93, no. 6, pp. 1551–1560, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. E. O. Koylu, P. R. Couceyro, P. D. Lambert, and M. J. Kuhar, “Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain,” Journal of Comparative Neurology, vol. 391, no. 1, pp. 115–132, 1998. View at Publisher · View at Google Scholar · View at Scopus
  86. Y. L. Hurd and P. Fagergren, “Human cocaine- and amphetamine-regulated transcript (CART) mRNA is highly expressed in limbic- and sensory-related brain regions,” Journal of Comparative Neurology, vol. 425, no. 4, pp. 583–598, 2000. View at Publisher · View at Google Scholar · View at Scopus
  87. E. J. Nestler and W. A. Carlezon Jr., “The mesolimbic dopamine reward circuit in depression,” Biological Psychiatry, vol. 59, no. 12, pp. 1151–1159, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. R. G. Hunter and M. J. Kuhar, “CART peptides as targets for CNS drug development,” Current Drug Target CNS Neurological Disorders, vol. 2, no. 3, pp. 201–205, 2003. View at Google Scholar · View at Scopus
  89. J. L. Cao, H. E. Covington III, A. K. Friedman et al., “Mesolimbic dopamine neurons in the brain reward circuit mediate susceptibility to social defeat and antidepressant action,” Journal of Neuroscience, vol. 30, no. 49, pp. 16453–16458, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. G. J. Kirouac, M. P. Parsons, and S. Li, “Innervation of the paraventricular nucleus of the thalamus from cocaine- and amphetamine-regulated transcript (CART) containing neurons of the hypothalamus,” Journal of Comparative Neurology, vol. 497, no. 2, pp. 155–165, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. S. C. Yang, J. T. Pan, and H. Y. Li, “CART peptide increases the mesolimbic dopaminergic neuronal activity: a microdialysis study,” European Journal of Pharmacology, vol. 494, no. 2-3, pp. 179–182, 2004. View at Publisher · View at Google Scholar · View at Scopus
  92. Z. Ma, E. Pearson, and R. Tao, “CART peptides increase 5-hydroxytryptamine in the dorsal raphe and nucleus accumbens of freely behaving rats,” Neuroscience Letters, vol. 417, no. 3, pp. 303–307, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. A. Vaarmann and A. Kask, “Cocaine and amphetamine-regulated transcript peptide (CART62-76)-induced changes in regional monoamine levels in rat brain,” Neuropeptides, vol. 35, no. 5-6, pp. 292–296, 2001. View at Publisher · View at Google Scholar · View at Scopus
  94. K. R. Shieh, “Effects of the cocaine- and amphetamine-regulated transcript peptide on the turnover of central dopaminergic neurons,” Neuropharmacology, vol. 44, no. 7, pp. 940–948, 2003. View at Publisher · View at Google Scholar · View at Scopus
  95. A. Vaarmann and A. Kask, “Cocaine and amphetamine-regulated transcript peptide (CART62-76)-induced changes in regional monoamine levels in rat brain,” Neuropeptides, vol. 35, no. 5-6, pp. 292–296, 2001. View at Publisher · View at Google Scholar · View at Scopus
  96. R. B. Rothman, N. Vu, X. Wang, and H. Xu, “Endogenous CART peptide regulates mu opioid and serotonin 5-HT2A receptors,” Peptides, vol. 24, no. 3, pp. 413–417, 2003. View at Publisher · View at Google Scholar · View at Scopus
  97. L. F. Harthoorn, A. Sañé, M. Nethe, and J. J. Van Heerikhuize, “Multi-transcriptional profiling of melanin-concentrating hormone and orexin-containing neurons,” Cellular and Molecular Neurobiology, vol. 25, no. 8, pp. 1209–1223, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. E. J. Huang and L. F. Reichardt, “Neurotrophins: roles in neuronal development and function,” Annual Review of Neuroscience, vol. 24, pp. 677–736, 2001. View at Publisher · View at Google Scholar · View at Scopus
  99. K. Hashimoto, E. Shimizu, and M. Iyo, “Critical role of brain-derived neurotrophic factor in mood disorders,” Brain Research Reviews, vol. 45, no. 2, pp. 104–114, 2004. View at Publisher · View at Google Scholar · View at Scopus
  100. Y. Li, B. W. Luikart, S. Birnbaum et al., “TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment,” Neuron, vol. 59, no. 3, pp. 399–412, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. H. D. Schmidt and R. S. Duman, “Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models,” Neuropsychopharmacology, vol. 35, no. 12, pp. 2378–2391, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. A. Lakatos, S. Prinster, A. Vicentic, R. A. Hall, and M. J. Kuhar, “Cocaine- and amphetamine-regulated transcript (CART) peptide activates the extracellular signal-regulated kinase (ERK) pathway in AtT20 cells via putative G-protein coupled receptors,” Neuroscience Letters, vol. 384, no. 1-2, pp. 198–202, 2005. View at Publisher · View at Google Scholar · View at Scopus
  103. S. S. Grewal, R. York, and P. J. Stork, “Extracellular-signal-regulated kinase signalling in neurons,” Current Opinion in Neurobiology, vol. 9, no. 5, pp. 544–553, 1999. View at Publisher · View at Google Scholar · View at Scopus
  104. H. Y. Chiu, H. H. Lin, and C. C. Lai, “Cocaine- and amphetamine-regulated transcript (CART) peptide activates ERK pathways via NMDA receptors in rat spinal cord dorsal horn in an age-dependent manner,” Regulatory Peptides, vol. 164, no. 2-3, pp. 90–96, 2010. View at Publisher · View at Google Scholar · View at Scopus
  105. A. Bonni, A. E. West, S. R. Datta, M. A. Takasu, and M. E. Greenberg, “Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and independent mechanisms,” Science, vol. 286, no. 5443, pp. 1358–1362, 1999. View at Publisher · View at Google Scholar · View at Scopus
  106. A. Riccio, S. Ahn, C. M. Davenport, J. A. Blendy, and D. D. Ginty, “Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons,” Science, vol. 286, no. 5448, pp. 2358–2361, 1999. View at Publisher · View at Google Scholar · View at Scopus
  107. N. Moragues, P. Ciofi, P. Lafon, G. Tramu, and M. Garret, “GABAA receptor epsilon subunit expression in identified peptidergic neurons of the rat hypothalamus,” Brain Research, vol. 967, no. 1-2, pp. 285–289, 2003. View at Google Scholar
  108. M. Backberg, C. Ultenius, J. M. Fritschy, and B. Meister, “Cellular localization of GABA receptor alpha subunit immunoreactivity in the rat hypothalamus: relationship with neurones containing orexigenic or anorexigenic peptides,” Journal of Neuroendocrinology, vol. 16, no. 7, pp. 589–604, 2004. View at Google Scholar
  109. S. Dallvechia-Adams, M. J. Kuhar, and Y. Smith, “Cocaine- and amphetamine-regulated transcript peptide projections in the ventral midbrain: colocalization with gamma-aminobutyric acid, melanin-concentrating hormone, dynorphin, and synaptic interactions with dopamine neurons,” The Journal of Comparative Neurology, vol. 448, no. 4, pp. 360–372, 2002. View at Google Scholar
  110. Y. Smith, E. O. Koylu, P. Couceyro, and M. J. Kuhar, “Ultrastructural localization of CART (cocaine- and amphetamine-regulated transcript) peptides in the nucleus accumbens of monkeys,” Synapse, vol. 27, no. 1, pp. 90–94, 1997. View at Publisher · View at Google Scholar · View at Scopus
  111. L. M. Stanek, “Cocaine- and amphetamine related transcript (CART) and anxiety,” Peptides, vol. 27, no. 8, pp. 2005–2011, 2006. View at Publisher · View at Google Scholar · View at Scopus
  112. A. Kask, H. B. Schiöth, F. Mutulis, J. E. Wikberg, and L. Rägo, “Anorexigenic cocaine- and amphetamine-regulated transcript peptide intensifies fear reactions in rats,” Brain Research, vol. 857, no. 1-2, pp. 283–285, 2000. View at Publisher · View at Google Scholar · View at Scopus
  113. S. Chaki, N. Kawashima, Y. Suzuki, T. Shimazaki, and S. Okuyama, “Cocaine- and amphetamine-regulated transcript peptide produces anxiety-like behavior in rodents,” European Journal of Pharmacology, vol. 464, no. 1, pp. 49–54, 2003. View at Publisher · View at Google Scholar · View at Scopus